Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Horse dander extract is a biological allergenic extract derived from the dander and hair of the horse (*Equus caballus*). It is utilized in clinical practice for the diagnosis and treatment of Type I hypersensitivity reactions to horse allergens. The extract contains a complex mixture of proteins, including the major allergen Equ c 1 (a lipocalin) and Equ c 2. For diagnostic purposes, it is used in skin prick testing to elicit a wheal-and-flare reaction by cross-linking allergen-specific IgE on the surface of cutaneous mast cells. For therapeutic purposes, it is administered via allergen-specific immunotherapy (AIT), typically through subcutaneous injections (SCIT). The mechanism of AIT involves the induction of peripheral T-cell tolerance, a shift from a Th2 to a Th1 immune response, and the production of "blocking" antibodies such as IgG4, which compete with IgE for allergen binding, thereby reducing allergic symptoms upon subsequent environmental exposure.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on horse dander extract.